Extension of organ transplantation: Some ethical considerations

Mount Sinai Journal of Medicine

Volumn 70, Issue 3, 2003, Pages 141-147

  Agich, George J ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Ethics; Organ transplantation

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; COST BENEFIT ANALYSIS; FUNCTIONAL ASSESSMENT; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMED CONSENT; MEDICAL ETHICS; ORGAN TRANSPLANTATION; PATIENT MONITORING; PATIENT RIGHT; QUALITY OF LIFE; RISK BENEFIT ANALYSIS;

COST-BENEFIT ANALYSIS; FEMALE; HAND; HUMANS; IMMUNOSUPPRESSION; INFORMED CONSENT; ORGAN TRANSPLANTATION; QUALITY OF LIFE; UTERUS;

EID: 0037650082     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Institute of Medicine Committee on Organ Procurement and Transplantation Policy. Organ procurement and transplantation: Assessing current policies and the potential impact of the DHHS final rule. Washington (DC): National Academy Press; 1999.
2. Moore FD. Three ethical revolutions: ancient assumptions remodeled under pressure of transplantation. Transplant Proc 1988; 20(1 Suppl 1):1061-1067.
3. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341(23):1725-1730.
4. Port FK, Wolfe RA, Mauger EA, et al. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993; 270:1339-1343.
5. Hunsicker LG. A survival advantage for renal transplantation. N Engl J Med 1999; 341(23):1762-1763.
6. Wicks MN, Milstead EJ, Hathaway DK, et al. Family caregivers' burden, quality of life, and health following patients' renal transplantation. J Transpl Coord 1998; 8(3):170-176.
7. Rebollo P, Ortega F, Baltar JM, et al. Health-related quality of life (HRQOL) in end stage renal disease (ESRD) patients over 65 years. Geriatr Nephrol Urol 1998; 8(2):85-94.
8. Matas AJ, Gillingham KJ, Payne WD, et al. A third kidney transplant: cost-effective treatment for end-stage renal disease? Clin Transpl 1996; 10:516-520.
9. Price CE, Lowe D, Cohen AT, et al. Prospective study of the quality of life in patients assessed for liver transplantation: outcome in transplanted and not transplanted groups. J R Soc Med 1995; 88:130-135.
10. DiMartini A, Rovera GM, Graham TO, et al. Quality of life after small intestinal transplantation and among home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1998; 22(6):357-362.
11. Bryan S, Ratcliffe J, Neuberger JM, et al. Health-related quality of life following liver transplantation. Qual Life Res 1998; 7:115-120.
12. Molzahn AE, Burton JR, McCormick P, et al. Quality of life of candidates for and recipients of heart transplants. Can J Cardiol 1997; 13(3):141-146.
13. Miles AM, Sumrani N, Horowitz R, et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation 1998; 65(3):380-384.
14. Winter P, Schoeneich G, Miersch WD, et al. Tumour induction as a consequence of immunosuppression after renal transplantation. Int Urol Nephrol 1997; 29(6):701-709.
15. Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999; 246(5):339-346.
16. Kann BR, Furnas DW, Hewitt CW. Past, present, and future research in the field of composite tissue allotransplantation. Microsurgery 2000; 20(8):393-399.
17. Lee WP. Composite tissue transplantation: more science and patience needed. Plast Reconstr Surg 2000; 107(4):1066-1070.
18. Lee WP, Mathes DW. Hand transplantation: pertinent data and future outlook. J Hand Surg [Am] 1999; 24(5):906-913.
19. Owen ER, Dubernard JM, Lanzetta M, et al. Peripheral nerve regeneration in human hand transplantation. Transplant Proc 2001; 33(1-2):1720-1721.
20. Dickenson D, Hakim NS. Ethical issues in limb transplants. Postgrad Med J 1999; 75(887):513-515.
21. Siegler M. Ethical issues in innovative surgery: should we attempt a cadaveric hand transplantation in a human subject? Transplant Proc 1998; 30:2779-2782.
22. Shieh SJ, Chiu HY, Hsu HY. Long-term effects of sensory reeducation following digital replantation and revascularization. Microsurgery 1998; 18(5):334-336.
23. Fukunishi I. Relationship of cosmetic disfigurement to the severity of posttraumatic stress disorder in burn injury or digital amputation. Psychother Psychosom 1999; 68(2):82-86.
24. Boulas HJ. Amputations of the fingers and hand: indications for replantation. J Am Acad Orthop Surg 1998; 6(2):100-105.
25. Strome M, Stein J, Esclamado R, et al. Laryngeal transplantation and 40-month follow-up. N Engl J Med 2001; 344(22):1676-1679.
26. Cooney WP, Hentz VR. Successful hand transplantation - one year follow-up. N Engl J Med 2001; 344(1):65.
27. Jones JW, Gruber SA, Barker JH, Breidenbach WC. Successful hand transplantation. One-year follow-up. N Engl J Med 2000; 343(7):468-473.
28. Francois CG, Breidenbach WC, Maldonado C, et al. Hand transplantation: comparisons and observations of the first four clinical cases. Microsurgery 2000; 20(8):360-371.
29. Dubernard JM, Owen E, Lefrancois N, et al. First human hand transplantation. ase report. Transpl Int 2000; 13(Suppl 1):S521-S524.
30. Dubernard JM, Owen ER, Lanzetta M, Hakim N. What is happening with hand transplants. Lancet 2001; 357(9269):1711-1712.
31. Pellegrino ED, Thomasma DC. For the patient's good: the restoration of beneficence in health care. New York and Oxford: Oxford University Press; 1988.
32. Moore FD. Therapeutic innovation: ethical boundaries in the initial clinical trials of new drugs and surgical procedures. CA Cancer J Clin 1970; 20(4):212-227.